Sunlight Tirzepatide Review: A Flat $157/Month, and What It Leaves Out (2026)

Sunlight charges a flat $157 a month for compounded tirzepatide — prescription, unlimited telehealth visits and shipping included, and the figure is published plainly on its own site rather than held back until intake (verified August 29, 2026). Compounded semaglutide starts at $88. It is LegitScript-certified. The catch is what a flat rate cannot tell you: Sunlight does not name the pharmacy that fills it.

What Sunlight is

Sunlight is a LegitScript-certified telehealth platform, positioning itself as a cost disruptor by bundling unlimited telehealth visits and free shipping into one flat monthly rate for compounded semaglutide and tirzepatide.

A real correction: Sunlight does publish an ongoing rate

This review's live check of Sunlight's own FAQ found a direct answer to what the drug actually costs, and verbatim: "Sunlight pricing is straightforward: semaglutide starts at $88 and tirzepatide at $157. Each flat monthly rate includes your prescription, unlimited telehealth visits, and free shipping with no hidden fees." That's a real, published ongoing rate — a genuine improvement over an earlier finding that Sunlight's site showed only a $239 first-month promotional price struck through from $379 with no stated month-two figure. Worth noting: a separate promotional banner elsewhere on the site may still show that introductory framing, so confirm which figure applies to your specific signup flow, but the FAQ's flat $157/month is the clearest published answer this review found.

The brand-vs-compounded question

Sunlight dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Sunlight's real strengths: genuine LegitScript certification, unlimited telehealth visits and free shipping bundled into the rate rather than billed as extras, and — per this review's own finding — a published, flat $157/month rate for tirzepatide specifically. The trade-offs: the legal entity name and state of incorporation are not disclosed anywhere this review found, the compounding pharmacy partner is not named, and per-state availability isn't listed. Sunlight is compounded only, with no brand-name pathway. As with any GLP-1 program, confirm which price applies to your specific signup — the promotional banner and the FAQ's flat rate may not be perfectly reconciled; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Sunlight is genuinely competitive on price — $157/month flat, in its own FAQ, with unlimited visits and shipping included — a real, published answer that an earlier pass of research couldn't find. It's a strong pick if you want a low, all-in flat rate and are comfortable with the compounding pharmacy remaining unnamed. Compare it against bmiMD or CoreAge Rx for similarly flat structures with more disclosed detail. See our best tirzepatide providers ranking for the full field.